Table 3.
The impact of opium use on the ICU rates, mortality, and need for intubation among hospitalized COVID-19 patients
Treatment | Outcome | Model | OR (95% CI) | P-value |
---|---|---|---|---|
Opium | ICU admission | PSM | 1.87 (0.22, 2.91) | 0.631 |
Unadjusted | 1.76 (0.36, 2.59) | 0.467 | ||
Full adjusted | ––– | –– | ||
Optimal model | 1.42 (0.14, 2.24) | 0.116 | ||
Opium | Mortality | PSM | 2.38 (1.30–4.35) | 0.005 |
Unadjusted | 2.19 (0.52, 3.74) | 0.679 | ||
Full adjusted | 2.34 (0.17, 3.74) | 0.697 | ||
Optimal model | 2.39 (0.13, 3.19) | 0.571 | ||
Opium | Need for intubation | PSM | 3.57 (1.38, 9.39) | 0.009 |
Unadjusted | 2.01 (0.97, 4.17) | 0.062 | ||
Full adjusted | 5.54 (1.97, 15.61) | 0.001 | ||
Optimal model | 6.34 (2.59, 15.50) | < 0.001 |
A full adjustment method was implemented, considering all variables. The selection of the optimal model was carried out through a backward stepwise algorithm. In the propensity score matching (PSM) approach, variables exhibiting significant associations with outcomes (ICU admission or mortality or need for intubation) or opioid use were taken into consideration. Caliper parameters were set at 0.5 for the three response variables, while the ratio was established at 3, 3, and 4 correspondingly. Potential confounding variables were carefully matched between the group of individuals who received opioids and the group of individuals who did not receive opioids